Aquilon Pharmaceuticals SA

Aquilon Pharmaceuticals SA is an SME in Vise, Belgium that has taken part in 1 EU-funded project since 2022, receiving €175k in EU funding.

EU funding received€175k
EU projects1
As coordinator0
Running now1
First EU project2022
Latest project2022
CountryBelgium
EU registration (PIC)894503640
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Aquilon Pharmaceuticals SA's own share of each project, not the project's full budget.

  • Horizon Europe€175k · 1 project

Projects

1 EU-funded project, newest first. Each links to the official record.

  • STOP SPREAD BAD BUGSPartner

    STOP SPREAD BAD BUGS: novel antimicrobial approaches to combat multidrug resistance in bacteria

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €175ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • bacteriology
  • multidrug resistance
  • pharmacokinetics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime